About the Aimedis project

Decentralized and incentivized healthcare Revolutionary AI & a sophisticated dual blockchain model
A fully operational medical ecosystem
A cutting-edge social medical network
Videochat, medical records, trackers, appointments, prescriptions
eLearning, scientific research & professional medical IT

Join us fighting cancer and get paid for living a healthier life!
Aimedis is already revolutionizing healthcare and is live in hospitals across Europe and Asia
ICO bench

Token presale has started

Token for Sale :300,000,000 AIM
Total Amount :600,000,000 AIM
Price / Token :0,12 USD

Welcome to Aimedis

Aimedis is an AI backed, blockchain and smart contract supported medical ecosystem, that changes the way patients, doctors, and hospitals communicate, connect and handle information.

Using the Aimedis platform, users can store, secure and share their medical information only with the people they want to share it with by using the Aimedis right management system.

Beside the records, AImedis offers videochat and communication with other patients and doctors, online prescriptions, online appointments, learning content, the inclusion of fitness trackers and devices like ECG or bloodpressure monitors into the system, while all transactions inside the system are backed by our porprietary AIMChain blockchain.

Aimedis is running in hospitals across Europe and Asia and is supporting scientific research to save lives

AIMEDIS is a real company already working in more than 20 hospitals in 3 countries
AIMEDIS already served over 10 000 patients
AIMEDIS is secured by two block-chains, private and public. They link with each-other in a immutable fashion
AIMEDIS provides not only a Patient to Doctor network, but also a Patient for Patient Social Media Platform which incentivizes contributions in form of AIM tokens
AIMEDIS allows patients to have control over their data and even sell it
AIMEDIS is lead by a team of word-class doctors and medical industry professionals

The token

The AIM token is used in several ways.

First, AIM holders will participate in the Aimedis health ecosystem and will be able to benefit from its applications and functionalities.

Second the pharmaceutical industry and scientific research facilities can pay patients a fee for participating in trials by granting access to dedicated areas of their medical records, which is 100% voluntary.

In the next step Aimedis will release AIMSocial, the platform that incentivises patients for helping and engaging with other patients.

Fair and incentivised support by patients for patients - worldwide.